Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.


Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Warning on foetal monitoring with cardiotocographs


A warning on foetal monitoring with cardiotocographs first made in 2002 has been repeated by the Medicines and Healthcare products Regulatory Agency.

Adverse outcomes are still being reported in the presence of CTG traces that appear normal. For example, the display of double maternal heart rate (MHR x 2) can be falsely reassuring, the MHRA warned.

It said cardiotocograph should not be relied upon in isolation to monitor the condition of the foetus and the presence of a foetal heartbeat should also be checked by independent means such as a Pinard stethoscope or hand-held Doppler.


Readers' comments (2)

  • Gail M Smith

    I've asked this before, but no response. Would it really be so difficult for you to include the link to the relevant article or statement? It would make things much easier for your readers who want more information, and I cannot believe that would be a problem for you, Nursing Times. Thank you.

    Unsuitable or offensive? Report this comment

  • Gail M Smith

    For anyone else interested, the pdf document link can be found on this page: There, simple.

    Unsuitable or offensive? Report this comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.